Non-melanoma Skin Cancer

Global Market Trajectory & Analytics

MCP13619

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

612

INTERACTIONS

122

PARTICIPANTS

24

VALIDATIONS

12

* Login to view program details and full enterprise executive list.

DATE
JULY 2020
TABLES
99
PAGES
175
EDITION
6
PRICE
USD $4950

COVID-19 IMPACT SURVEY

Amid the COVID-19 crisis, the global market for Non-melanoma Skin Cancer estimated at US$499.8 Million in the year 2020, is projected to reach a revised size of US$682.4 Million by 2027, growing at a CAGR of 4.5% over the period 2020-2027.Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is projected to grow at a 4.4% CAGR to reach US$442.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Squamous Cell Carcinoma (SCC) segment is readjusted to a revised 4.9% CAGR for the next 7-year period. This segment currently accounts for a 34.4% share of the global Non-melanoma Skin Cancer market.

The Non-melanoma Skin Cancer market in the U.S. is estimated at US$147.2 Million in the year 2020. The country currently accounts for a 29.44% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$120.9 Million in the year 2027 trailing a CAGR of 4.3% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR while Rest of European market (as defined in the study) will reach US$120.9 Million by the year 2027.We bring years of research experience to this 6th edition of our report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others, Bausch Health Companies Inc.; F. Hoffmann-La Roche AG; Sun Pharmaceutical Industries Ltd.

» Segment (Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC)) » Treatment (Radiation Therapy, Other Treatments)

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

A:

ACTIVE CLIENT
B:

INACTIVE CLIENT
C:

ACTIVE PANELIST
D:

INACTIVE PANELIST
E:

OPT-INS

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.)

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

REPORT INDEX PROJECT COMPENDIUM * EXPERT PANEL

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Non-melanoma Skin Cancer Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Non-melanoma Skin Cancer Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
Non-melanoma Skin Cancer Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
Non-melanoma Skin Cancer Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Basal Cell Carcinoma (BCC) (Segment) World Market by Region/Country in US$ Thousand: 2020 to 2027
Basal Cell Carcinoma (BCC) (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
Basal Cell Carcinoma (BCC) (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Squamous Cell Carcinoma (SCC) (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
Squamous Cell Carcinoma (SCC) (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
Squamous Cell Carcinoma (SCC) (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Radiation Therapy (Treatment) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
Radiation Therapy (Treatment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
Radiation Therapy (Treatment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Other Treatments (Treatment) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
Other Treatments (Treatment) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019
Other Treatments (Treatment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Non-melanoma Skin Cancer Market Share (in %) by Company: 2019 & 2025
United States Non-melanoma Skin Cancer Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027
Non-melanoma Skin Cancer Market in the United States by Segment: A Historic Review in US$ Thousand for 2012-2019
United States Non-melanoma Skin Cancer Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
United States Non-melanoma Skin Cancer Market Estimates and Projections in US$ Thousand by Treatment: 2020 to 2027
Non-melanoma Skin Cancer Market in the United States by Treatment: A Historic Review in US$ Thousand for 2012-2019
United States Non-melanoma Skin Cancer Market Share Breakdown by Treatment: 2012 VS 2020 VS 2027
CANADA
Canadian Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027
Canadian Non-melanoma Skin Cancer Historic Market Review by Segment in US$ Thousand: 2012-2019
Non-melanoma Skin Cancer Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
Canadian Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Treatment: 2020 to 2027
Canadian Non-melanoma Skin Cancer Historic Market Review by Treatment in US$ Thousand: 2012-2019
Non-melanoma Skin Cancer Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2012, 2020, and 2027
JAPAN
Japanese Market for Non-melanoma Skin Cancer: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027
Non-melanoma Skin Cancer Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019
Japanese Non-melanoma Skin Cancer Market Share Analysis by Segment: 2012 VS 2020 VS 2027
Japanese Market for Non-melanoma Skin Cancer: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2020-2027
Non-melanoma Skin Cancer Market in Japan: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2012-2019
Japanese Non-melanoma Skin Cancer Market Share Analysis by Treatment: 2012 VS 2020 VS 2027
CHINA
Chinese Non-melanoma Skin Cancer Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027
Non-melanoma Skin Cancer Historic Market Analysis in China in US$ Thousand by Segment: 2012-2019
Chinese Non-melanoma Skin Cancer Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
Chinese Non-melanoma Skin Cancer Market Growth Prospects in US$ Thousand by Treatment for the Period 2020-2027
Non-melanoma Skin Cancer Historic Market Analysis in China in US$ Thousand by Treatment: 2012-2019
Chinese Non-melanoma Skin Cancer Market by Treatment: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Non-melanoma Skin Cancer Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Non-melanoma Skin Cancer Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
Non-melanoma Skin Cancer Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
European Non-melanoma Skin Cancer Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027
Non-melanoma Skin Cancer Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019
European Non-melanoma Skin Cancer Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
European Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Treatment: 2020-2027
Non-melanoma Skin Cancer Market in Europe in US$ Thousand by Treatment: A Historic Review for the Period 2012-2019
European Non-melanoma Skin Cancer Market Share Breakdown by Treatment: 2012 VS 2020 VS 2027
FRANCE
Non-melanoma Skin Cancer Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027
French Non-melanoma Skin Cancer Historic Market Scenario in US$ Thousand by Segment: 2012-2019
French Non-melanoma Skin Cancer Market Share Analysis by Segment: 2012 VS 2020 VS 2027
Non-melanoma Skin Cancer Market in France by Treatment: Estimates and Projections in US$ Thousand for the Period 2020-2027
French Non-melanoma Skin Cancer Historic Market Scenario in US$ Thousand by Treatment: 2012-2019
French Non-melanoma Skin Cancer Market Share Analysis by Treatment: 2012 VS 2020 VS 2027
GERMANY
Non-melanoma Skin Cancer Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027
German Non-melanoma Skin Cancer Historic Market Analysis in US$ Thousand by Segment: 2012-2019
German Non-melanoma Skin Cancer Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
Non-melanoma Skin Cancer Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2020-2027
German Non-melanoma Skin Cancer Historic Market Analysis in US$ Thousand by Treatment: 2012-2019
German Non-melanoma Skin Cancer Market Share Breakdown by Treatment: 2012 VS 2020 VS 2027
ITALY
Italian Non-melanoma Skin Cancer Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027
Non-melanoma Skin Cancer Historic Market Analysis in Italy in US$ Thousand by Segment: 2012-2019
Italian Non-melanoma Skin Cancer Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
Italian Non-melanoma Skin Cancer Market Growth Prospects in US$ Thousand by Treatment for the Period 2020-2027
Non-melanoma Skin Cancer Historic Market Analysis in Italy in US$ Thousand by Treatment: 2012-2019
Italian Non-melanoma Skin Cancer Market by Treatment: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
United Kingdom Market for Non-melanoma Skin Cancer: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027
Non-melanoma Skin Cancer Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019
United Kingdom Non-melanoma Skin Cancer Market Share Analysis by Segment: 2012 VS 2020 VS 2027
United Kingdom Market for Non-melanoma Skin Cancer: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2020-2027
Non-melanoma Skin Cancer Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2012-2019
United Kingdom Non-melanoma Skin Cancer Market Share Analysis by Treatment: 2012 VS 2020 VS 2027
REST OF EUROPE
Rest of Europe Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027
Non-melanoma Skin Cancer Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019
Rest of Europe Non-melanoma Skin Cancer Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
Rest of Europe Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Treatment: 2020-2027
Non-melanoma Skin Cancer Market in Rest of Europe in US$ Thousand by Treatment: A Historic Review for the Period 2012-2019
Rest of Europe Non-melanoma Skin Cancer Market Share Breakdown by Treatment: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Non-melanoma Skin Cancer Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027
Asia-Pacific Non-melanoma Skin Cancer Historic Market Scenario in US$ Thousand by Segment: 2012-2019
Asia-Pacific Non-melanoma Skin Cancer Market Share Analysis by Segment: 2012 VS 2020 VS 2027
Non-melanoma Skin Cancer Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Thousand for the Period 2020-2027
Asia-Pacific Non-melanoma Skin Cancer Historic Market Scenario in US$ Thousand by Treatment: 2012-2019
Asia-Pacific Non-melanoma Skin Cancer Market Share Analysis by Treatment: 2012 VS 2020 VS 2027
REST OF WORLD
Rest of World Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027
Rest of World Non-melanoma Skin Cancer Historic Market Review by Segment in US$ Thousand: 2012-2019
Non-melanoma Skin Cancer Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
Rest of World Non-melanoma Skin Cancer Market Estimates and Forecasts in US$ Thousand by Treatment: 2020 to 2027
Rest of World Non-melanoma Skin Cancer Historic Market Review by Treatment in US$ Thousand: 2012-2019
Non-melanoma Skin Cancer Market in Rest of World: Percentage Share Breakdown of Sales by Treatment for 2012, 2020, and 2027
IV. COMPETITION
Total Companies Profiled : 1.8
Click here to request a full table of contents and more details on this project.
V. CURATED RESEARCH

INSIDER ACCESS TO
  METHODOLOGY
  QUESTIONNAIRE
  INFLUENCER NETWORK

YOUR PRIVACY MATTERS!

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

●   projects
Complimentary previews of full stack research data for participated
●  Insider access to research programs including engagements and stats from other panelists

●  Unlimited research credits of $1000 per participated project

●  Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company

●  Interact with other panelists via our MarketGlass^TM Data Exchange Platform*

●  BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

*Complete details will be shared with panelists upon formal acceptance.

GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com